Abstract
Cromoglycate inhibits a number of allergic reactions and in particular the allergen-induced bronchospasm in patients with extrinsic asthma; clinical findings which are outside the scope of this chapter have been reviewed by Pepys (1973) and Brogden et al. (1974). Laboratory studies revealed that this compound was neither a bronchodilator nor an antagonist of histamine, 5-hydroxytryptamine (5-HT) nor slow reacting substance of anaphylaxis (SRS-A), the suspected mediators of allergic bronchospasm, but rather prevented the anaphylactic release of these mediators (Cox, 1967; Cox et al., 1970). Lymphocyte functions correlated with the cell-mediated immune response were not inhibited by the drug (Walker and Dolby, 1975). In animals and man, cromoglycate inhibits immediate hypersensitivity reactions provoked by several different antigens, suggesting that it does not act by blocking the antibody receptor for antigen. This has been confirmed by Orr et al. (1970 a) in studies using double sensitization with two antigenically distinct rat reagins. Furthermore, since the compound is effective in passively sensitized tissues, and in clinical usage does not reduce serum IgE levels (Berg and Johansson, 1971), it does not act by inhibiting antibody production. These observations, together with results described in detail in later sections, suggest that an important part of the clinical efficacy of cromoglycate may be attributed to prevention of exocytosis in mast cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altounyan, R.E.C.: Inhibition of experimental asthma by a new compound-disodium cromoglycate “Intal”. Acta allerg. (Kbh.) 22, 487 (1967)
Amundsen, E., Ofstad, E., Hagen, P.-O.: Histamine release induced by synergistic action of kallikrein and phospholipase A. Arch. int. Pharmacodyn. 178, 104–114 (1969)
Anderson, P., Slorach, S.A., Uvnäs, B.: Sequential exocytosis of storage granules during antigen-induced histamine release from sensitized rat mast cells in vitro. An electron microscopic study. Acta physiol. scand. 88, 359–372 (1973)
Ankier, S.I.: Disodium cromoglycate and inhibition of passive cutaneous anaphylaxis. Int. Arch. Allergy 41,163–165(1971)
Ankier, S.I., Neat, M.L.: Some studies on acute inflammation induced by dextran in the mouse. Int. Arch. Allergy 42, 264–277 (1972)
Ashton, M. J., Clark, B., Jones, K.M., Moss, G.F., Neale, M.G., Ritchie, J.T.: The absorption, metabolism, and excretion of disodium cromoglycate in nine animal species. Toxicol. appl. Pharmacol. 26, 319–328 (1973)
Assem, E.S.K.: Inhibition of allergic reactions by cromoglycate and by a new series of compounds (AH 6556, AH 7079, and AH 7725). Int. Arch. Allergy 45, 708–718 (1973)
Assem, E.S.K., Atkinson, G.: Histamine release by MCDP (401), a peptide from the venom of the honey bee. Brit. J. Pharmacol. 48, 337 P–338 P (1973)
Assem, E.S.K., Evans, J.A., McAllen, M.: Inhibition of experimental asthma in man by a new drug (AH 7725) active when given by mouth. Brit. med. J. 2, 93–94 (1974)
Assem, E.S.K., Mongar, J.L.: Inhibition of allergic reactions in man and other species by cromoglycate. Int. Arch. Allergy. 38, 68–77 (1970)
Assem, E.S.K., Richter, A.W.: Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by β-adrenergic stimulants and disodium cromoglycate. Immunology 21, 729–739(1971)
Assem, E.S.K., Schild, H.O.: Detection of allergy to penicillin and other antigens by in vitro passive sensitization and histamine release from human and monkey lung. Brit. med. J. 1968III, 272–276
Assem, E.S.K., Schild, H.O.: Inhibition by sympathomimetic amines of histamine release by antigen in passively sensitised human lung. Nature (Lond.) 224, 1028–1029 (1969)
Austen, K.F., Brocklehurst, W.E.: Inhibition of the anaphylactic release of histamine from chopped guinea-pig lung by chymotrypsin substrates and inhibitors. Nature (Lond.) 186, 866–868 (1960)
Austen, K.F., Brocklehurst, W.E.: Anaphylaxis in chopped guinea-pig lung. I. Effect of peptidase substrates and inhibitors. J. exp. Med. 113, 521–539 (1961)
Barker, G., Ellis, G.P., Shaw, D.: Benzopyrones. 9. Synthesis and pharmacology of some novel bischromones. J. med. Chem. 16, 87–89 (1973)
Barlow, R.B.: Introduction to Chemical Pharmacology, 2nd Ed., p. 270. London: Methuen 1964
Batchelor, J.F., Follenfant, M.J., Garland, L.G., Gorvin, J.H., Green, A.F., Hodson, H.F., Hughes, D.T.D., Tateson, J.E.: Doxantrazole, an antiallergic agent orally effective in man. Lancet 1975I, 1169–1170
Baxter, J.H.: Histamine release from rat mast cells by dextran: Effects of adrenergic agents, theophylline and other drugs. Proc. Soc. exp. Biol. (N.Y.) 141, 576–581 (1972)
Baxter, J.H.: Role of Ca++ in mast cell activation, desensitization, and histamine release by dextran. J. Immunol. 111, 1470–1473 (1973)
Baxter, J.H., Adamik, R.: Temperature dependence of histamine release from rat mast cells by dextran. Proc. Soc. exp. Biol. (N.Y.) 146, 1–74 (1974)
Baxter, J.H., Adamik, R.: Control of histamine release: effects of various conditions on rate of release and rate of cell desensitization. J. Immunol. 114, 1034–1041 (1975)
Benner, M., Lowell, F.C.: Failure of diethylcarbamazine citrate (Hetrazan) in the treatment of asthma. J. Allergy 46, 29–31 (1970)
Benson, M.K., Curry, S.H., D’A Mills, G.G., Hughes, D.T.D.: Uptake of disodium cromoglycate in obstructive airways disease. Clin. Allergy 3, 389–394 (1973)
Berg, T., Johansson, S.G.O.: In vitro diagnosis of atopic allergy. Int. Arch. Allergy 41, 452–462 (1971)
Berger, F.M., Fukui, G., Ludwig, B.J., Margolin, S.: Selective suppression of penicillin hypersensitivity by certain phenoxy propanediols. Proc. Soc. exp. Biol. (N.Y.) 124, 303–310 (1967)
Binaghi, R.A., Benacerraf, B., Bloch, K.J., Kourilsky, F.M.: Properties of rat anaphylactic antibody. J. Immunol. 92, 927–933 (1964)
Bloch, K.J., Morse, H.C., Austen, K.F.: Biologic properties of rat antibodies. I. Antigen-binding by four classes of anti-DNP antibodies. J. Immunol. 101, 650–657 (1968)
Bloch, K.J., Wilson, R.J.M.: Homocytotropic antibody response in the rat infected with the nematode, Nippostrongylus brasiliensis. III. Characteristics of the antibody. J. Immunol. 100, 629–636(1968)
Blum, J., Ovary, Z.: Evaluation of methods of measurements of permeability increases. Int. Arch. Allergy 46, 121–127(1974)
Bonaccorsi, A., West, G.B.: Absence of capillary permeability response in rats to dextran and egg-white. J. Pharm. (Lond.) 15, 372–378 (1963)
Boura, A.L.A., Mongar, J.L., Schild, H.O.: Improved automatic apparatus for pharmacological assays on isolated preparations. Brit. J. Pharmacol. 9, 24–30 (1954)
Bourne, H.R., Lichtenstein, L.M., Melmon, K.L.: Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3′,5′-adenosine monophosphate in human leukocytes. J. Immunol. 108, 695–705 (1972)
Breithaupt, H., Habermann, E.: Mastzelldegranulierendes Peptid (MCD-Peptid) aus Bienengift: Isolierung, biochemische und pharmakologische Eigenschaften. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 261, 252–270 (1968)
Brocklehurst, W.E., Humphrey, J.H., Perry, W.L.M.: The role of histamine in cutaneous antigen-antibody reactions in the rat. J. Physiol. (Lond.) 129, 205–224 (1955)
Brocklehurst, W.E., Humphrey, J.H., Perry, W.L.M.: Cutaneous antigen-antibody reactions in the rat. J. Physiol. (Lond.) 150, 489–500 (1960)
Broder, L., Taichman, N.S.: Mechanism of histamine release from perfused guinea-pig lung by soluble immune complexes. Immunology 21, 193–205 (1971)
Brogden, R.M., Speight, T.M., Avery, G.S.: Sodium cromoglycate (Cromolyn Sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs 7, 164–282 (1974)
Broughton, B.J., Chaplen, P., Knowles, P., Lunt, E., Pain, D.L., Wooldridge, K.R.H., Ford, R., Marshall, S., Walker, J.L., Maxwell, D.R.: New inhibitor of reagin-mediated anaphylaxis. Nature (Lond.) 251, 650–652 (1974)
Broughton, B.J., Chaplen, P., Knowles, P., Lunt, E., Marshall, S.M., Pain, D.L., Wooldridge, K.R.H.: Antiallergic activity of 2-phenyl-8-azapurin-6-ones. J. med. Chem. 18, 1117–1122(1975)
Bryant, D.H., Burns, M.W., Lazarus, L.: New type of allergic asthma due to IgG “reaginic” antibody. Brit. med. J. 1973IV, 589–592
Bryant, D.H., Burns, M.W., Lazarus, L.: Identification of IgG antibody as a carrier of reaginic activity in asthmatic patients. J. Allergy clin. Immunol. 56, 417–428 (1975)
Buckle, D.R., Cantello, B.C.C., Morgan, N.J., Smith, H., Spicer, B.A.: Antiallergic activity of ω-nitroacetophenones. J. med. Chem. 18, 733–736 (1975 b)
Buckle, D.R., Cantello, B.C.C., Smith, H., Spicer, B.A.: Antiallergic activity of 4-hydroxy-3-nitro-coumarins. J. med. Chem. 18, 391–394 (1975 c)
Buckle, D.R., Cantello, B.C.G, Smith, H., Spicer, B.A.: 4-Hydroxy-3-nitro-2-quinolones and related compounds as inhibitors of allergic reactions. J. med. Chem. 18, 726–732 (1975d)
Buckle, D.R., Morgan, N.J., Ross, J.W., Smith, H., Spicer, B.A.: Antiallergic activity of 2-nitroin-dan-1,3-diones. J. med. Chem. 16, 1334–1339 (1973)
Buckle, D.R., Morgan, N.J., Smith, H.: Hydroaromatic analogues of 2-nitro-1,3-indandiones. J. med. Chem. 18, 203–206 (1975 a)
Burden, D.T., Parkes, M.W., Gardiner, D.G.: Effect of /?-adrenoceptive blocking agents on the response to bronchoconstrictor drugs in the guinea-pig air over-flow preparation. Appendix describing a new modification of the air overflow method. Brit. J. Pharmacol. 41, 122–131 (1971)
Burka, J.F., Eyre, P.: A study of prostaglandins and prostaglandin antagonists in relation to anaphylaxis in calves. Canad. J. Physiol. Pharmacol. 52, 942–951 (1974)
Burka, J.F., Eyre, P.: Modulation of the formation and release of bovine SRS-A in vitro by several anti-anaphylactic drugs. Int. Arch. Allergy 49, 774–781 (1975)
Cairns, H., Fitzmaurice, C., Hunter, D., Johnson, P.B., King, J., Lee, T.B., Lord, G.H., Minshull, R., Cox, J.S.G.: Synthesis and structure-activity relationships of disodium cromoglycate and some related compounds. J. med. Chem. 15, 583–589 (1972)
Chakrin, L.W., Mengel, J., Young, D., Zaher, C., Krell, R.D., Wardell, J.R.: Enhancement of immediate-type hypersensitivity reactions by N-methyl-N′ {2[(4-methyl-5-imidazolyl)me-thylthio]ethyl} thio urea (SK & F 92058), a histamine H2-receptor antagonist. Fed. Proc. 33, 585 (1974)
Chasin, M., Harris, D.N., Phillips, M.B., Hess, S.M.: 1-Ethyl-4-(isopropylidenehydrazino)-1 H-pyrazolo(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009): a potent new inhibitor of cyclic 3′,5′-nucleotide phosphodiesterases. Biochem. Pharmacol. 21, 2443–2450(1972)
Church, M.K., Collier, H.O.J., James, G.W.L.: The inhibition by dexamethasone and disodium cromoglycate of anaphylactic bronchoconstriction in the rat. Brit. J. Pharmacol. 46, 56–65 (1972)
Coulson, C.J., Ford, R.E, Lunt, E., Marshall, S., Pain, D.L., Rogers, LH., Wooldridge, K.R.H.: Antiallergic activity of a series of 8-azaxanthines. Eur op. J. med. Chem. Chim. Ther. 9, 313–317(1974)
Cox, J.S.G.: Disodium cromoglycate (FPL 670) (“Intal”): a specific inhibitor of reaginic antibody—antigen mechanisms. Nature (Lond.) 216, 1328–1329 (1967)
Cox, J.S.G.: Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. Brit. J. Dis. Chest 65, 189–204 (1971)
Cox, J.S.G., Altounyan, R.E.C.: Nature and modes of action of disodium cromoglycate (Lomudal). Respiration 27 (Suppl), 292–309 (1970)
Cox, J.S.G., Beach, J.E., Blair, A.M.J.N., Clarke, A.J., King, J., Lee, T.B., Loveday, D.E.E., Moss, G.F., Orr, T.S.C., Ritchie, J.T., Sheard, P.: Disodium cromoglycate (Intal). In: Ad-vances in Drug Research, Vol. V, pp. 115–196. London-New York: Academic Press 1970
Crunkhorn, P., Willis, A.L.: Cutaneous reactions to intradermal prostaglandins. Brit. J. Pharmacol. 41, 49–56 (1971)
Curry, S.H., Taylor, A.J., Evans, S., Godfrey, S., Zeidifard, E.: Disposition of disodium cromoglycate administered in three particle sizes. J. Pharm. (Lond.) 26 Suppl., 79 P (1974)
Danaraj, T.J.: The treatment of eosinophilic lung (tropical eosinophilia) with diethylcarbamazine. Quart. J. Med. 27, 243–263 (1958)
Davies, G.E.: Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63197). J. Pharm. (Lond.) 25, 681–689 (1973)
Davies, G.E., Evans, D.P.: Studies with two new phosphodiesterase inhibitors (ICI 58301 and ICI 63197) on anaphylaxis in guinea-pigs, mice, and rats. Int. Arch. Allergy 45, 467–478 (1973)
Dawson, W., Tomlinson, R.: Effect of cromoglycate and eicosatetraynoic acid on the release of prostaglandins and SRS-A from immunologically challenged guinea-pig lungs. Brit. J. Pharmacol. 52, 107 P–108 P (1974)
Despopoulos, A.: Antihemolytic actions of tricyclic tranquilizers. Structural correlations. Biochem. Pharmacol. 19, 2907–2914 (1970)
Drain, D.J., Davy, B., Horlington, M., Howes, J.G.B., Scruton, J.M., Selway, R.A.: The effects of substituting tetrazole for carboxyl in two series of anti-inflammatory phenoxyacetic acids. J. Pharm. (Lond.) 23, 857–864 (1971)
Easty, D.L., Rice, N.S.C., Jones, B.R.: Clinical trial of topical disodium cromoglycate in vernal kerato-conjunctivitis. Clin. Allergy 2, 99–107 (1972)
Ellis, G.P., Shaw, D.: Benzopyrones. 7. Synthesis and antiallergic activity of some 2-(5-Tetrazolyl) chromones. J. med. Chem. 15, 865–867 (1972)
Evans, D.P., Gilman, D.J., Thomson, D.S., Waring, W.S.: Inhibition of allergic reactions by a novel phenanthroline ICI 74917. Nature (Lond.) 250, 592–593 (1974)
Evans, D.P., Lewis, J.A., Thomson, D.S.: An automated fluorimetric assay for the rapid determi-nation of histamine in biological fluids. Life Sci. 12, 327–336 (1973)
Evans, D.P., Marshall, P.W., Thomson, D.S.: Inhibition of immediate hypersensitivity reactions in the rat by ICI 74917 and disodium cromoglycate. Int. Arch. Allergy 49, 417–427 (1975)
Evans, D.P., Thomson, D.S.: Histamine release from rat mast cells passively sensitised with homocytotropic (IgE) antibody. Int. Arch. Allergy 43, 217–231 (1972)
Evans, D.P., Thomson, D.S.: Inhibition of immediate hypersensitivity reactions in laboratoryanimals by a phenanthroline salt (ICI 74917). Brit. J. Pharmacol. 53, 409–418 (1975)
Eyre, P., Lewis, A.J., Wells, P.W.: Acute systemic anaphylaxis in the calf. Brit. J. Pharmacol. 47, 504–516(1973)
Farmer, J.B., Richards, I.M., Sheard, P., Woods, A.M.: Passive lung anaphylaxis in the rat. Inhibition by disodium cromoglycate (Die Hemmung der passiven Lungen-Anaphylaxis in der Ratte durch di-Natrium Cromoglycate). Naunyn-Schmiedebergs Arch. Pharmacol. 279 Suppl., R 35 (1973)
Farmer, J.B., Richards, I.M., Sheard, P., Woods, A.M.: Mediators of passive lung anaphylaxis in the rat. Brit. J. Pharmacol. 55, 57–64 (1975)
Ferraresi, R.W., Roszkowski, A.R, Kepel, E.: Sodium 7-methylsulfinylxanthone-2-carboxylate(SMX), a potent inhibitor of rat reaginic-mediated inflammation. Fed. Proc. 33, 762 (1974)
Follenfant, M.J., Garland, L.G., Green, A.F., Tateson, J.E.: 3-(5-tetrazolyl) thioxanthone 10,10-dioxide (TTD) a new orally effective antiallergic. In: Proceedings Sixth International Congress of Pharmacology, Helsinki: p. 360. Sanomaprint (1975 a)
Follenfant, M.J., Garland, L.G., Green, A.F., Tateson, J.E.: Some properties of the antiallergic agent 3-(5-tetrazolyl) thioxanthone 10,10-dioxide (TTD) related to its possible mechanism of action. In: Proceedings Sixth International Congress of Pharmacology, Helsinki: p. 360. Sanomaprint (1975 b)
Foreman, J.C., Garland, L.G.: Desensitization in the process of histamine secretion induced by antigen and dextran. J. Physiol. (Lond.) 239, 381–391 (1974)
Foreman, J.C., Garland, L.G., Mongar, J.L.: The role of calcium in secretory processes: model studies in mast cells. In: Duncan, C.J. (Ed.): Calcium in Biological Systems, Society of Experimental Biology Symposium, pp. 193–218. Cambridge: Cambridge University Press 1976
Foreman, J.C., Hallett, M.B., Mongar, J.L.: 45-Calcium uptake in rat peritoneal mast cells. Brit. J. Pharmacol. 55, 283 P–284 P (1975)
Foreman, J.C., Mongar, J.L.: The role of the alkaline earth ions in anaphylactic histamine secretion. J. Physiol. (Lond.) 224, 753–769 (1972)
Foreman, J.C., Mongar, J.L., Gomperts, B. D.: Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature (Lond.) 245, 249–251 (1973)
Fredholm, B.: Studies on a mast cell degranulating factor in bee venom. Biochem. Pharmacol. 15, 2037–2043 (1966)
Fullarton, J., Martin, L.E., Vardey, C.: Studies on the inhibition of cellular anaphylaxis. Int. Arch. Allergy 45, 84–86 (1973 a)
Fullarton, J., Vardey, C.J., Atkinson, J.: Comparison of the release of histamine from rat mast cells and human basophil leucocytes. Paper read to the British Society for Immunology, Autumn Meeting (1973 b)
Gardiner, T.H., Schanker, L.S.: Absorption of disodium cromoglycate (DSCG) from the rat lung: evidence of carrier transport. Fed. Proc. 33, 513 (1974)
Garland, L.G.: Effect of cromoglycate on anaphylactic histamine release from rat peritoneal mast cells. Brit. J. Pharmacol. 49,128–130 (1973)
Garland, L.G.: The action of drugs that suppress histamine release from mast cells. University of London: Ph.D. Thesis 1975
Garland, L.G., Mongar, J.L.: Inhibition by cromoglycate of histamine release from rat peritoneal mast cells induced by mixtures of dextran, phosphatidyl serine and calcium ions. Brit. J. Pharmacol. 50, 137–143 (1974)
Garland, L.G., Mongar, J.L.: Differentiation by inhibitors between histamine release induced by dextran and by the ionophore A 23187. Proceedings Sixth International Congress of Pharmacology, p. 361. Helsinki: Samonaprint 1975
Garland, L.G., Mongar, J.L.: Differential histamine release by dextran and the ionophore A 23187: the actions of inhibitors. Int. Arch. Allergy 50, 27–42 (1976)
Goose, J., Blair, A.M.J.N.: Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate. Immunology 16, 749–760 (1969)
Goth, A., Adams, H.R., Knoohuizen, M.: Phosphatidylserine: selective enhancer of histamine release. Science 173, 1034–1035 (1971)
Greaves, M.W.: The effect of disodium cromoglycate and other inhibitors on in vitro anaphylactic histamine release from guinea-pig basophil leucocytes. Int. Arch. Allergy 36, 497–505 (1969)
Greaves, M.W., Fairley, V.M., Yamamoto, S.: Release of histamine from skin during in vitro anaphylaxis. Int. Arch. Allergy 41, 932–939 (1971)
Greaves, M.W., Yamamoto, S., Fairley, V.M.: IgE-mediated hypersensitivity in human skin studied using a new in vitro method. Immunology 23, 239–248 (1972)
Haddad, Z.H., Gillman, S.A.: Disodium cromoglycate and human reagin (IgE) mediated reactions. Int. Arch. Allergy 45 439–446 (1973)
Hall, C.M., Johnson, H.G., Wright, J.B.: Quinoline derivatives as antiallergy agents. J. med. Chem. 17, 685–690(1974)
Hanahoe, T.H.R, Holliman, A., Gordon, D., Wieczorek, W.: Disodium cromoglycate and the dextran response in rats. J. Pharm. (Lond.) 24, 666–667 (1972)
Herbst, R.M.: Tetrazoles as carboxylic acid analogs. In: Graff, S. (Ed.): Essays in Biochemistry, pp. 141–155. New York: John Wiley and Sons Inc. 1956
Herzig, D.J., Giles, R.E., Schumann, P.R., Kusner, E.J., Dubnick, B.: 3-(Hydroxymethyl)-8-me-thoxychromone: a new, orally active specific prophylactic inhibitor of reaginic anaphylaxis. Fed. Proc. 34, 760 (1975)
Herzig, D.J., Schumann, P.R., Kusner, E.J., Robichaud, L., Giles, R.E., Dubnick, B., von Strandtmann, M, Klutchko, S., Cohen, M. P., Shavel, J. Jr.: The search for specific inhibitors of immediate hypersensitivity reactions. The activity of some chromones in various laboratory models. In: Immunopharmacology, pp. 103–124. New York: Spectrum Press 1975. In press
Hines, M.C., Moss, G.F., Cox, J.S.G.: Effect of disodium cromoglycate on phospholipase A activity. Studies with egg yolk and isolated mast cell systems. Biochem. Pharmacol. 21, 171–179(1972)
Högberg, B., Uvnäs, B.: The mechanism of the disruption of mast cells produced by Compound 48/80. Acta physiol. scand. 41, 345–369 (1957)
Holland, A., Jackson, D., Chaplen, P., Lunt, E., Marshall, S.M., Pain, D.L., Wooldridge, K.: Antiallergic activity of 8-azapurin-6-ones with heterocyclic 2-substituents. Europ. J. Med. Chem-Chim. Ther. 10, 447–449 (1975)
Ishizaka, K., Ishizaka, T.: Role of IgE and IgG antibodies in reaginic hypersensitivity in the respiratory tract. In: Austen, K.F., Lichtenstein, L.M. (Eds.): Asthma: Physiology, Immuno-pharmacology, and Treatment, pp. 55–68. New York: Academic Press 1973
Ishizaka, T., Ishizaka, K., Lichtenstein, L. M.: Antibody-induced histamine release and degranula- tion of human basophil leukocytes. Fed. Proc. 30,654 (1971 a)
Ishizaka, T., Ishizaka, K., Orange, R.P., Austen, K.F.: Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J. Immunol. 106, 1267–1273 (1971 b)
Jasani, B., Stanworth, D.R.: Studies on the mast cell triggering action of certain artificial histamine liberators. Int. Arch. Allergy 45, 74–81 (1973)
Johnson, A.R., Moran, N.C.: Release of histamine from rat mast cells: a comparison of the effects of 48/80 and two antigen-antibody systems. Fed. Proc. 28, 1716–1720 (1969)
Johnson, H.G., Bach, M.K.: Prevention of calcium ionophore-induced release of histamine in rat mast cells by disodium cromoglycate. J. Immunol. 114, 514–516 (1975)
Johnson, H.G., Vanhout, C.A.: The enhanced efficacy of disodium cromoglycate (DSCG) in DSCG predosed rats. Proc. Soc. exp. Biol. (N.Y.) 143, 427–432 (1973)
Johnson, H.G., Vanhout, C.A.: Studies on the mode of action of disodium cromoglycate (DSCG). Enhanced efficacy in predosed rats. Allergol. Immunopath. (Madr.) 2, 33–40 (1974)
Jones, V.E., Ogilvie, B.M.: Reaginic antibodies and immunity to Nippostrongylus brasiliensis in the rat. II. Some properties of the antibodies and antigens. Immunology 12, 583–597 (1967)
Juby, P.F., Hudyma, T.W., Brown, M.: Preparation and antiinflammatory properties of some 5-(2-anilinophenyl) tetrazoles. J. med. Chem. 11, 111–117 (1968)
Kaliner, M., Austen, K.F.: A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitised human lung tissue. J. exp. Med. 138, 1077–1094 (1973)
Kaliner, M., Austen, K.F.: Cyclic nucleotides and modulations of effector systems of inflammation. Biochem. Pharmacol. 23, 763–771 (1974a)
Kaliner, M., Austen, K.F.: Hormonal control of the immunologic release of histamine and slowreacting substance of anaphylaxis from human lung. In: Braun, W., Lichtenstein, L.M., Parker, C.W. (Eds.): Cyclic AMP, Cell Growth and the Immune Response, pp. 163–175. Berlin-Heidelberg-New York: Springer 1974 b
Kimura, I., Tanizaki, Y., Sato, S., Takahashi, K., Saito, K., Ueda, N.: Morphological changes of basophils in immunological reactions-effect of sodium cromoglycate. Clin. Allergy 5, 181–187(1975)
Konzett, H., Rossler, R.: Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 195, 71–74 (1940)
Koopman, W.J., Orange, R.P., Austen, K.F.: Immunochemical and biologic properties of rat IgE. III. Modulation of the IgE-mediated release of slow-reacting substance of anaphylaxis by agents influencing the level of cyclic 3′,5′-adenosine monophosphate. J. Immunol. 105, 1096–1102 (1970 a)
Koopman, W.J., Orange, R.P., Austen, K.F.: Inhibition by antihistamines of the immunologic release of slow reacting substance of anaphylaxis (SRS-A) in the rat. Trans. Ass. Amer. Phycns 83, 225–234 (1970 b)
Kunze, H., Vogt, W.: Significance of phospholipase A for prostaglandin formation. Ann. N.Y. Acad. Sci. 180, 123–125 (1971)
Kusner, E.J., Dubnick, B., Herzig, D.J.: The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. J. Pharmacol, exp. Ther. 184, 41–46(1973)
Kusner, E.J., Herzig, D.J.: An automated fluorimetric method for the determination of histamine from mast cell suspension. In: Advances in Automated Analysis, Vol. II, pp. 429–433. Miami: Thurman Associates 1971
Levine, B.B., Chang, H., Vaz, N.M.: The production of hapten-specific reaginic antibodies in the guinea-pig. J. Immunol. 106, 29–33 (1971)
Lewis, R.A., Wasserman, S.I., Goetzl, E.J., Austen, K.F.: Formation of slowreacting substance of anaphylaxis in human lung tissue and cells before release. J. exp. Med. 140, 1133–1146 (1974)
Lichtenstein, L.M.: The immediate allergic response: in vitro separation of antigen activation, decay and histamine release. J. Immunol. 107, 1122–1130 (1971)
Lichtenstein, L.M.: The role of the cyclic AMP system in inflammation: An introduction. In: Braun, W., Lichtenstein, L.M., Parker, C.W. (Eds.): Cyclic AMP, Cell Growth and the Immune Response, pp. 147–162. Berlin-Heidelberg-New York: Springer 1974
Lichtenstein, L.M., Adkinson, N.F.: Chlorphenesin: a new inhibitor of IgE-mediated histamine release. J. Immunol. 103, 866–868 (1969)
Lichtenstein, L.M., Bourne, H.R.: Inhibition of allergic histamine release by histamine and other agents which stimulate adenyl cyclase. In: Austen, K.F., Becker, E.L. (Eds.): Biochemistry of the Acute Allergic Reactions, pp. 161–173. Oxford: Blackwell 1971
Lichtenstein, L.M., Debernardo, R.: The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release. J. Immunol. 107, 1131–1136(1971)
Lichtenstein, L.M., Gillespie, E.: Inhibition of histamine release by histamine controlled by H2 receptor. Nature (Lond.) 244, 287–288 (1973)
Lichtenstein, L.M., Gillespie, E.: The effects of the H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine. J. Pharmacol, exp. Ther. 192, 441–450 (1975)
Lichtenstein, L.M., Margolis, S.: Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161, 902–903 (1968)
Lichtenstein, L.M., Osler, A.G.: Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen. J. exp. Med. 120, 507–530(1964)
Lopez, M., Bloch, K.J.: Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions. J. Immunol. 103, 1428–1430 (1969)
McManus, J.M., Herbst, R.M.: Tetrazole analogues of amino acids. J. org. Chem. 24, 1643–1649 (1959)
Maling, H.M., Webster, M.E., Williams, M.A., Saul, W., Anderson, W.: Inflammation induced by histamine, serotonin, bradykinin, and compound 48/80 in the rat: antagonists and the mech-anism of action. J. Pharmacol, exp. Ther. 191, 300–310 (1974)
Mallen, M.S.: Treatment of intractable asthma with diethylcarbamazine citrate. Ann. Allergy 23, 534–537(1965)
Malley, A., Baecher, L.: Inhibition of histamine and SRS-A from monkey lung tissue by chlorphenesin. J. Immunol. 107, 586–588 (1971)
Marshall, P.W., Thomson, D.S., Evans, D.P.: The mechanism of tachyphylaxis to ICI 74917 and disodium cromoglycate. Int. Arch. Allergy 51, 274–283 (1976)
Marshall, R.: Protective effect of disodium cromoglycate on rat peritoneal mast cells. Thorax 27, 38–43 (1972)
Martin, L.E.: Inhibition of cellular anaphylaxis by beta-stimulants. Postgrad, med. J. 47, suppl., 26–30(1971)
Mielens, Z.E., Ferguson, E.W., Rosenberg, F.J.: Effects of anti-anaphylactic drugs upon passive cutaneous anaphylaxis mediated by graded doses of reaginic or non-reaginic antibodies in rats. Int. Arch. Allergy 47, 633–649 (1974)
Mihina, J.S., Herbst, R.M.: The reaction of nitriles with hydrazoic acid: synthesis of monosubsti-tuted tetrazoles. J. org. Chem. 15, 1082–1092 (1950)
Miyamoto, T., Reynolds, L.B., Patterson, R., Cugell, P.W., Kettel, L.J.: Respiratory changes in passively sensitised dogs and monkeys as models of allergic asthma. Amer. Rev. resp. Dis. 97, 76–88(1968)
Mongar, J.L., Schild, H.O.: Cellular mechanisms in anaphylaxis. Physiol. Rev. 42, 226–270 (1962)
Mongar, J.L., Svec, P.: The effect of phospholipids on anaphylactic histamine release. Brit. J. Pharmacol. 46, 741–752 (1972)
Moran, N.C., Uvnäs, B., Westerholm, B.: Release of 5-hydroxytryptamine and histamine from rat mast cells. Acta physiol. scand. 56, 26–41 (1962)
Morse, H.C., Austen, K.F., Bloch, K.J.: Biological properties of rat antibodies. III. Histamine release mediated by two classes of antibodies. J. Immunol. 102, 327–337 (1969)
Moss, G.F., Jones, K.M., Ritchie, J.T., Cox, J.S.G.: Distribution and metabolism of disodium cromoglycate in rats. Toxicol. appl. Pharmacol. 17, 691–698 (1970)
Moss, G.F., Jones, K.M., Ritchie, J.T., Cox, J.S.G.: Plasma levels and urinary excretion of diso-dium cromoglycate after inhalation by human volunteers. Toxicol. appl. Pharmacol. 20, 147–156(1971)
Moss, G. F., Ritchie, J. T.: The absorption and clearance of disodium cromoglycate from the lung in rat, rabbit, and monkey. Toxicol. appl. Pharmacol. 17, 699–707 (1970)
Mota, I.: The mechanism of anaphylaxis. I. Production and biological properties of “mast cell sensitizing” antibody. Immunology 7, 681–699 (1964)
Mota, I.: Biological characterisation of mouse “early” antibodies. Immunology 12, 343–348 (1967)
Mota, I., Dias da Silva, W.: The anti-anaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells. Brit. J. Pharmacol. 15, 396–404 (1960)
Neale, M.G., Moss, G.F.: Effect of inducers on the metabolism and excretion of disodium cromo-glycate in rats. Biochem. J. 130, 85 P–86 P (1972)
Newman, D.J., Spainhour, Jr., C.B., Brann, E.G.: Partial purification and properties of cAMP-phosphodiesterase isolated from guinea pig tracheal muscle. Fed. Proc. 34, 261 Abstr. (1975)
Nohara, A., Kuriki, H., Saijo, T., Ukawa, K., Murata, T., Kanno, M., Sanno, Y.: Studies on anti-anaphylactic agents. 4. Synthesis and structure-activity relationships of 3-(4-oxo-4H-l-ben-zopyran-3) acrylic acids, a new series of antiallergic substances, and some related com-pounds. J. med. Chem. 18, 34–37 (1975)
Ogilvie, B.M.: Reagin-like antibodies in animals immune to helminth parasites. Nature (Lond.) 204, 91–92(1964)
Orange, R.P., Austen, K.F.: Pharmacologic dissociation of immunologic release of histamine and slow reacting substance of anaphylaxis in rats. Proc. Soc. exp. Biol. (N.Y.) 129, 836–841 (1968)
Orange, R.P., Austen, K.F.: Slow reacting substance of anaphylaxis in the rat. In: Cellular and Humoral Mechanisms in Anaphylaxis and Allergy, pp. 196–206. Basel-New York: Karger 1969
Orange, R.P., Austen, K.F.: Drug-induced modulation of the immunologic release of histamine and slow reacting substance of anaphylaxis. Int. Arch. Allergy 41, 79–85 (1971)
Orange, R.P., Austen, W.G., Austen, K.F.: Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. J. exp. Med. 134, 136–148 (1971)
Orange, R.P., Murphy, R.C., Karnovsky, M.L., Austen, K.F.: The physicochemical characteristics and purification of slow reacting substance of anaphylaxis. J. Immunol. 110, 760–770 (1973)
Orange, R.P., Stechschulte, D.J., Austen, K.F.: Immunochemical and biological properties of rat IgE. II. Capacity to mediate the immunologic release of histamine and slow reacting substance of anaphylaxis (SRS-A). J. Immunol. 105, 1087–1095 (1970)
Orange, R.P., Valentine, M.D., Austen, K.F.: Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody. J. exp. Med. 127, 767–782(1968)
Orr, T.S.C.: The mast cell and disodium cromoglycate in immediate type reactions. Acta tuberc. pneumol. belg. 65, 300–307 (1974)
Orr, T.S.C., Blair, A.M.J.N.: Potentiated reagin response to egg albumin and conalbumin in Nippostrongylus brasiliensis infected rats. Life Sci. 8, 1073–1077 (1969)
Orr, T.S.C., Cox, J.S.G.: Disodium cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature (Lond.) 223, 197–198 (1969)
Orr, T.S.C., Gwilliam, J., Cox, J.S.G.: Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7Sγ2 antibody. Immunology 19, 469–479 (1970b)
Orr, T.S.C., Gwilliam, J., Cox, J.S.G.: Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-DNP 7Sγ2 and rat reagin induced cutaneous reactions. Immunology 21, 405–417 (1971 a)
Orr, T.S.C., Hall, D.E., Gwilliam, J.M., Cox, J.S.G.: The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48/80. Life Sci. 10, 805–812 (1971b)
Orr, T.S.C., Pollard, M.C., Gwilliam, J., Cox, J.S.G.: Mode of action of disodium cromoglycate studies on immediate type hypersensitivity reactions using “double sensitization” with two antigenically distinct rat reagins. Clin. exp. Immunol. 7, 745–757 (1970 a)
Orr, T.S.C., Riley, P., Doe, J.E.: Potentiated reagin response to egg albumin in Nippostrongylus brasiliensis infected rats. II. Time course of the reagin response. Immunology 20, 185–189 (1971c)
Parish, W.E.: Release of histamine and slow reacting substance with mast cell changes after challenge of human lung sensitized passively with reagin in vitro. Nature (Lond.) 215, 738–739 (1967)
Parish, W.E.: A human heat-stable anaphylactic or anaphylactoid antibody which may partici-pate in pulmonary disorders. In: Austen, K.F., Lichtenstein, L.M. (Eds.): Asthma: Physiol-ogy, Immunopharmacology, and Treatment, pp. 71–89. New York: Academic Press 1973
Parish, W.E.: Some biological activities of IgG subclass antibodies after inoculation and in disease. In: Ganderton, M. A., Frankland, A. W. (Eds.): Allergy 74, Proceedings of the Ninth European Congress of Allergology and Clinical Immunology, pp. 153–175. New York: Pitman Medical Publ. 1975
Parratt, J.R., West, G.B.: 5-Hydroxytryptamine and tissue mast cells. J. Physiol. (Lond.) 137, 169–178 (1957 a)
Parratt, J.R., West, G.B.: Release of 5-hydroxytryptamine and histamine from tissues of the rat. J. Physiol. (Lond.) 137, 179–192 (1957 b)
Parratt, J.R., West, G.B.: 5-Hydroxytryptamine and the anaphylactoid reaction in the rat. J. Physiol. (Lond.) 139, 27–41 (1957 c)
Patterson, R., Talbot, C.H.: Respiratory responses in sub-human primates with immediate-type hypersensitivity. J. Lab. clin. Med. 73, 924–933 (1969)
Patterson, R., Talbot, C.H., Brandfonbrener, M.: The use of IgE mediated responses as a pharma-cologic test system. The effect of disodium cromoglycate in respiratory and cutaneous reactions and on the electrocardiograms of rhesus monkeys. Int. Arch. Allergy 41, 592–603 (1971)
Pearce, C.A., Greaves, M.W., Plummer, V.M., Yamamoto, S.: Effect of disodium cromoglycate on antigen-evoked histamine release from human skin. Clin. exp. Immunol. 17, 437–440 (1974)
Pepys, J.: Disodium cromoglycate in clinical and experimental asthma. In: Austen, K.F., Lichtenstein, L.M. (Eds.): Asthma: Physiology, Immunopharmacology, and Treatment, pp. 279–292. New York: Academic Press 1973
Piper, P.J., Walker, J.L.: The release of spasmogenic substances from human chopped lung tissue and its inhibition. Brit. J. Pharmacol. 47, 291–304 (1973)
Pfister, J.R., Ferraresi, R.W., Harrison, I.T., Rooks, W.H., Roszkowski, A.P., Van Horn, A.: Xan-thone-2-carboxylic acids, a new series of antiallergic substances. J. med. Chem. 15, 1032–1035 (1972)
Possanza, G.J., Bauen, A., Stewart, P.B.: Effect of a benzopyrano benzopyran (PR-D-92-EA) on the mediators of allergy in vitro. Pharmacologist 16,198 (1974)
Possanza, G.J., Bauen, A., Stewart, P.B.: In vitro antagonism of the mediators of allergy by a benzopyrano-benzopyran carboxylic acid PR-D-92-EA. Int. Arch. Allergy 49, 789–795 (1975)
Poyser, R.H., West, G.B.: Structural requirements of sugars as antagonists of the vascular response to dextran in rat skin. Brit. J. Pharmacol. 32, 219–226 (1968)
Rachelefsky, G.S., Lavin, N., Kaplan, S.A.: An action of cromolyn sodium (CS): Inhibition of cyclic 3′,5′-adenosine monophosphate (cAMP) phosphodiesterase (PDE). J. Allergy 55, 117–118(1975)
Riley, P.A., Sheard, P., Clarke, A.J., Orr, T.S.C.: The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG. Life Sci. 17, 793–802 (1975)
Roesch, E., Roesch, A.: The local dextran reaction in skin of rats as influenced by beta-adrenergic mechanisms and the cyclic AMP-system. Naunyn Schmiedeberg’s Arch. Pharmacol. 279, R 15 (1973)
Ross, J.W., Smith, H., Spicer, B.A.: Increased vascular permeability during passive peritoneal anaphylaxis (PPA) in the rat. The effects of disodium cromoglycate and a nitroindandione. Int. Arch. Allergy 51, 226–237 (1976)
Roszkowski, A.P., Ferraresi, R.W., Schuler, M.E., Sullivan, B.J.: Pharmacological properties of sodium 7-isopropoxy-xanthone 2-carboxylate (IXC). Fed. Proc. 33, 569 (1974)
Rothschild, A.M.: Histamine release by bee venom phospholipase A and mellitin in the rat. Brit. J. Pharmacol. 25, 59–66 (1965)
Rothschild, A.M.: Mechanisms of histamine release by compound 48/80. Brit. J. Pharmacol. 38, 253–262(1970)
Roy, A.C., Warren, B.T.: Inhibition of cAMP phosphodiesterase by disodium cromoglycate. Biochem. Pharmacol. 23, 917–920 (1974)
Schmutzler, W., Derwall, R., Poblete Freundt, G.: The effects of catecholamines and of disodium cromoglycate (DSCG) on the cyclic AMP and the anaphylactic release of histamine in the guinea pig lung. Naunyn Schmiedeberg’s Arch. Pharmacol. 277, R67 (1973)
Sheard, P., Blair, A.M.J.N.: Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung. Int. Arch. Allergy 38, 217–224 (1970)
Sheard, P., Killingback, P.G., Blair, A.M. J.N.: Antigen induced release of histamine and SRS-A from human lung passively sensitized with reaginic serum. Nature (Lond.) 216, 283–284 (1967)
Sheppard, H., Wiggan, G.: Different sensitivities of the phosphodiesterases (adenosine-3′,5′-cyclic phosphate 3′-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold. Biochem. Pharmacol. 20, 2128–2130 (1971)
Shore, P.A., Burkhalter, A., Cohn, V.H.: A method for the fluorometric assay of histamine in tissues. J. Pharmacol, exp. Ther. 127, 182–186 (1959)
Siraganian, P.A., Siraganian, R.P.: Basophil activation by concanavalin A: characteristics of the reaction. J. Immunol. 112, 2117–2125 (1974)
Spicer, B.A., Ross, J.W., Smith, H.: Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and a nitroindanedione. Clin. exp. Immunol. 21, 419–429 (1975)
Sprenkle, A.C., Van Arsdel, P.P., Bierman, C.W.: New class of antiallergic compounds effective in man. J. Allergy 55, 118 (1975)
Stechschulte, D.J., Orange, R.P., Austen, K.F.: Immunochemical and biologic properties of rat IgE. I. Immunochemical identification of rat IgE. J. Immunol. 105, 1082–1086 (1970)
Stewart, P.B., Bell, R., Goodfriend, L.: Pharmacological differentiation of monkey lung and skin mast cell-reagin reactions in vitro. In: Goodfriend, L., Sehon, A.H., Orange, R.P. (Eds.): Mechanisms in Allergy. Reagin-Mediated Hypersensitivity, pp. 457–466. New York: Marcel Dekker Inc. 1973
Stewart, P.B., Devlin, J.P., Freier, K.R.: Anti-allergic activity of a benzopyrano benzopyran PR-D-92-EA. Fed. Proc. 33, 762 (1974)
Stotland, L.M., Share, N.N.: Pharmacological studies on active bronchial anaphylaxis in the rat. Canad. J. Physiol. Pharmacol. 52, 1119–1125 (1974)
Taichman, N.S., Movat, H.Z.: Do polymorphonuclear leukocytes play a role in passive cutaneous anaphylaxis of the guinea-pig? Int. Arch. Allergy 30, 97–102 (1966)
Tateson, J.E., Trist, D.G.: Inhibition of adenosine-3′,5′-cyclic monophosphate phosphodiesterase by potential antiallergic compounds. Life Sci. 18, 153–162 (1976)
Tattrie, N.H.: Positional distribution of saturated and unsaturated fatty acids on egg lecithin. J. Lipid Res. 1, 60–65 (1959)
Tay, GH., Yeoh, T.S., Greaves, M.W.: Spontaneous and evoked histamine release from guinea pig skin in vitro in presence of disodium cromoglycate. Int. Arch. Allergy 43, 390–394 (1972)
Taylor, G., Shivalkar, P.R.: Disodium cromoglycate: laboratory studies and clinical trial in al-lergic rhinitis. Clin. Allergy 1, 189–198 (1971)
Taylor, W.A.: The effect of disodium cromoglycate and PGF2α on acute cutaneous reactions of the guinea pig and rat. Int. Arch. Allergy 45, 82–83 (1973)
Taylor, W.A.: Control of mast cell degranulation. In: Ganderton, M.A., Frankland, A. W. (Eds.): Allergy 74. Proceedings of the Ninth European Congress of Allergology and Clinical Immunology, pp. 256–266. New York: Pitman Medical Publishers 1975
Taylor, W.A., Francis, D.H., Sheldon, D., Roitt, I.M.: The anti-anaphylactic actions of disodium cromoglycate, theophylline, isoprenaline, and prostaglandins. Int. Arch. Allergy 46, 104–120 (1974 a)
Taylor, W.A., Francis, D.H., Sheldon, D., Roitt, I.M.: Anti-allergic actions of disodium cromogly-cate and other drugs known to inhibit cyclic 3′,5′-nucleotide phosphodiesterase. Int. Arch. Allergy 47, 175–193 (1974 b)
Taylor, W.A., Roitt, I.M.: Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig. Int. Arch. Allergy 45, 795–807 (1973)
Taylor, W.A., Sheldon, D.: Mast cell degranulation. A comparison of the inhibitory actions of disodium cromoglycate, drugs known to influence the level of intracellular cyclic nucleotide and diisopropylfluorophosphate (DFP). Int. Arch. Allergy 47, 696–707 (1974)
Thomson, D.S., Evans, D.P.: Inhibition of immediate hypersensitivity reactions by disodium cromoglycate. Requirements for activity in two laboratory models. Clin. exp. Immunol. 13, 537–544(1973)
Udaka, K., Takeuchi, Y., Movat, H.Z.: Simple method for quantitation of enhanced vascular permeability. Proc. Soc. exp. Biol. (N.Y.) 133, 1384–1387 (1970)
Uvnäs, B., Antonsson, J.: Triggering action of phosphatidase A and chymotrypsins on degranulation of rat mesentery mast cells. Biochem. Pharmacol. 12, 867–873 (1963)
Voorhees, A.B., Baker, H.J., Pulaski, E.J.: Reactions of albino rats to injections of dextran. Proc. Soc. exp. Biol. (N.Y.) 76, 254–256 (1951)
Walker, D.M., Dolby, A.E.: Effect of disodium cromoglycate on lymphocyte response to antigen and mitogen. Int. Arch. Allergy 49, 303–309 (1975)
Walker, S.R., Evans, M.E., Richards, A.J., Paterson, J.W.: The fate of [14C] disodium cromoglycate in man. J. Pharm. (Lond.) 24, 525–531 (1972)
Watanabe, S., Nakamura, K., Koda, A.: Experimental asthma caused by homocytotropic anti-body in guinea pigs. Proceedings Sixth International Congress of Pharmacology, p. 494. Helsinki: Sanomaprint 1975
Wells, P.W., Eyre, P.: The pharmacology of passive cutaneous anaphylaxis in the calf. Canad. J. Physiol. Pharmacol. 50, 255–262 (1972)
Wright, J.B., Johnson, H.G.: Antiasthma agents. I. 4-Oxo-4#-[l]benzothieno[3,2-b]pyran-2-carboxylic acid and 4-oxo-4 H-[l]benzofuro[3,2-b]pyran-2-carboxylic acid. J. med. Chem. 16,861–862(1973)
Zeller, E.A., Bissegger, A.: Über die Cholin-esterase des Gehirns und der Erythrocyten. Helv. chim. Acta 26, 1619–1630 (1943)
Zvaifler, N.J., Bauer, H., Robinson, J.O.: IgE immunoglobulin in the rabbit. In: Austen, K.F., Becker, E. L. (Eds.): Biochemistry of the Acute Allergic Reactions, pp. 34–42. Oxford: Black-well 1971
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Garland, L.G., Green, A.F., Hodson, H.F. (1979). Inhibitors of the Release of Anaphylactic Mediators. In: Vane, J.R., Ferreira, S.H. (eds) Anti-Inflammatory Drugs. Handbook of Experimental Pharmacology, vol 50 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66891-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-66891-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66893-7
Online ISBN: 978-3-642-66891-3
eBook Packages: Springer Book Archive